Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048
      QxMD      Google Scholar   
Citation:
J. Clin. Oncol vol 36 (31) 3120-25
Year:
2018
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
Book Volume:
8
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Health Outcome
Sec. Committees:
GI    
Pharmas:
Novartis  
Grants:
UG1CA189823, U10CA180821, U10CA180882, U10CA180791, U10CA180822, U10CA180838, U10CA180857, U10CA180858, U10CA180867, U10CA180868, U10CA21661, U10CA37422, HHSN261201000063C  
Corr. Author:
 
Authors:
                                         
Primary Study
N1048
Secondary Studies:
Phases:
2/3
Keywords: